Literature DB >> 19288919

[Therapeutic efficacy of naphthoquine phosphate combined with artemisinine against Plasmodium knowlesi].

Jing-yan Wang1, De-ben Ding, Guo-fu Li, Jing-hua Zhao.   

Abstract

OBJECTIVE: To study the antimalarial activity of naphthoquine phosphate combined with artemisinine against Plasmodium knowlesi in rhesus monkey.
METHODS: Monkeys were randomly divided into 9 groups (3/group). The monkeys in groups A and B were treated i.g. once daily for 3 days with 6 or 10 mg/kg of naphthoquine phosphate respectively. Those in groups C and D were treated i.g. twice for the 1st day and once for the 2nd and 3rd day with 31.6 or 100 mg/kg of artemisinine respectively. In groups E, F and G, they were treated i.g. only once with the combination of naphthoquine phosphate 10 mg/kg and artemisinine 10, 20 or 25 mg/kg respectively. Groups H and I served as controls which were treated i.g. only once with 10 mg/kg of naphthoquine phosphate and 30 mg/kg of artemisinine respectively. Parasitemia was examined beginning 24 h after drug administration. The observation lasted 105 days when no more parasite was found.
RESULTS: At 24 h after drug administration, the parasite reduction rate in all groups was higher than 90%. The parasite clearance time for groups E, F and G was (56.0 +/- 16.0), (53.3 +/- 4.6), and (56.0 +/- 8.0) h respectively, more rapid than that of Group H [(69.3 +/- 4.6) h]. There were 1, 3, 3, 2, 2, and 3 monkeys in groups A, B, D, E, F, and G respectively which were cured. No monkeys were cured in groups C, H and I.
CONCLUSION: The combination of naphthoquine phosphate and artemisinine is superior to the single component and the optimum proportion in the combination is 1 : 2.5 in treating P. knowlesi infection in monkeys.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19288919

Source DB:  PubMed          Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi        ISSN: 1000-7423


  3 in total

Review 1.  Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.

Authors:  Brioni R Moore; Moses Laman; Sam Salman; Kevin T Batty; Madhu Page-Sharp; Francis Hombhanje; Laurens Manning; Timothy M E Davis
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

2.  Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections.

Authors:  Cyrus Daneshvar; Timothy M E Davis; Janet Cox-Singh; Mohammad Z Rafa'ee; Siti K Zakaria; Paul C S Divis; Balbir Singh
Journal:  Malar J       Date:  2010-08-19       Impact factor: 2.979

3.  Susceptibility of human Plasmodium knowlesi infections to anti-malarials.

Authors:  Farrah A Fatih; Henry M Staines; Angela Siner; Mohammed Atique Ahmed; Lu Chan Woon; Erica M Pasini; Clemens Hm Kocken; Balbir Singh; Janet Cox-Singh; Sanjeev Krishna
Journal:  Malar J       Date:  2013-11-19       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.